Peer reviewed grant will support company’s vision to develop compassionate AI for mental health conditions
— Dr. Peter O. Owotoki, Co-Founder and CEO
KRONBERG, HESSE, GERMANY, October 15, 2020 /EINPresswire.com/ — Vitafluence.ai, a German Medtech start-up and leader in the compassionate Artificial Intelligence (AI) field, announces today that it is a recipient of a non-dilutive grant from the Hessian Ministry of Economics. The grant is financed by the European Regional Development Fund (ERDF). The Peer-Reviewed grant will cover 45% of R&D costs of Vitafluence.ai, until the end of 2022, to develop its first digital Biomarker for Autism Spectrum Disorders (ASD).
Autism is a complex neurodevelopmental disorder that is characterized by social, communication, learning, and…